| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/11/2000 | US6013649 Bond disorders; autoimmune diseases; antitumor agents |
| 01/11/2000 | US6013648 Immunomodulators |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013646 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/11/2000 | US6013626 To inhibit the proliferation of mammalian cells; antitumor agents |
| 01/11/2000 | US6013619 Applying gas positive end-expiratory pressure with ventilator into lung section of mammal, instilling lavage composition containing dilute surfactant in a pharmaceutically acceptable aqueous medium into lung, removing pulmonary fluid |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013479 Human Emr1-like G protein coupled receptor |
| 01/11/2000 | US6013458 Conformationally constrained compounds which mimic the secondary structure of biologically active peptides and proteins; for screening libraries |
| 01/11/2000 | US6013450 CAF1-related protein |
| 01/11/2000 | US6013279 Combination preparation for stimulating the growth of hair and optionally the growth of skin and nails as well as for preventing or eliminating the loss of hair |
| 01/11/2000 | US6013278 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013253 Administering combination of consensus interferon and interleukin-1 receptor antagonist to reduce weight loss associated with treatmet of multiple sclerosis with using interferon alone |
| 01/11/2000 | US6013067 Methods for increasing hematopoietic cells |
| 01/11/2000 | CA2195027C Hiv protease inhibitors useful for the treatment of aids |
| 01/06/2000 | WO2000000629A1 High efficiency retroviral vectors that contain none of viral coding sequences |
| 01/06/2000 | WO2000000622A2 Human oxidoreductase proteins |
| 01/06/2000 | WO2000000612A1 A novel human thrombopoietin mutein |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000609A2 Molecules associated with apoptosis |
| 01/06/2000 | WO2000000608A2 Immune system molecules |
| 01/06/2000 | WO2000000604A1 Methods and compositions for modulating spermatogenesis |
| 01/06/2000 | WO2000000603A2 Modularly constructed rna molecules having two sequence region types |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000489A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 01/06/2000 | WO2000000488A1 Muscarinic antagonists |
| 01/06/2000 | WO2000000487A1 5-ht1f agonists |
| 01/06/2000 | WO2000000484A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 01/06/2000 | WO2000000483A2 Tubulin binding compounds (cobra) |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000473A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | WO2000000469A2 Alkyl ketones as potent anti-cancer agents |
| 01/06/2000 | WO2000000207A1 Treatment of hyperproliferative disorders |
| 01/06/2000 | WO2000000203A1 Azepine derivatives having effects on serotonin related systems |
| 01/06/2000 | WO2000000202A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 01/06/2000 | WO2000000201A1 BICYCLIC sPLA2 INHIBITORS |
| 01/06/2000 | WO2000000198A1 Piperidine derivatives having effects on serotonin related systems |
| 01/06/2000 | WO2000000196A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 01/06/2000 | WO2000000189A1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 01/06/2000 | WO2000000158A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
| 01/06/2000 | WO2000000157A2 Use of tempo and tempo derivatives for inducing cell death |
| 01/06/2000 | WO2000000120A1 Methods and transdermal compositions for pain relief |
| 01/06/2000 | WO2000000039A1 Process and product for promoting weight loss in overweight dogs |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999056723A3 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 01/06/2000 | WO1999051185A3 Human galactosyl transferases |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | WO1999043829A3 Cell cycle related proteins |
| 01/06/2000 | WO1999043661A3 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 01/06/2000 | WO1999017759A3 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/06/2000 | WO1999000137A3 Induction of an activated myeloid dendritic cell phenotype |
| 01/06/2000 | WO1998034942A3 Dinucleotides and their use |
| 01/06/2000 | CA2337999A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2336309A1 Tubulin binding compounds (cobra) |
| 01/06/2000 | CA2336306A1 Indium photosensitizers for pdt |
| 01/06/2000 | CA2336254A1 5-ht1f agonists |
| 01/06/2000 | CA2336117A1 Piperidine derivatives having effects on serotonin related systems |
| 01/06/2000 | CA2336108A1 Alkyl ketones as potent anti-cancer agents |
| 01/06/2000 | CA2336089A1 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 01/06/2000 | CA2335986A1 Use of tempo and tempo derivatives for inducing cell death |
| 01/06/2000 | CA2335921A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | CA2335846A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 01/06/2000 | CA2335837A1 Methods and transdermal compositions for pain relief |
| 01/06/2000 | CA2335791A1 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2335448A1 Bicyclic spla2 inhibitors |
| 01/06/2000 | CA2335310A1 Azepine derivatives having effects on serotonin related systems |
| 01/06/2000 | CA2334897A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2332379A1 Molecules associated with apoptosis |
| 01/06/2000 | CA2332175A1 Modularly constructed rna molecules having two sequence region types |
| 01/06/2000 | CA2331779A1 Methods and compositions for modulating spermatogenesis |
| 01/06/2000 | CA2331399A1 Thienopyridine compounds, their production and use |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2331380A1 Human oxidoreductase proteins |
| 01/06/2000 | CA2330546A1 Immune system molecules |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/06/2000 | CA2330110A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 01/05/2000 | EP0969013A1 Peptides for inhibiting HPV E7 proteins |
| 01/05/2000 | EP0969005A1 Azabicyclic inhibitors of serotonin reuptake |
| 01/05/2000 | EP0968432A1 Growth factor-dependent diseases |
| 01/05/2000 | EP0968304A1 Identification of inhibitors of protein tyrosine kinase 2 |
| 01/05/2000 | EP0968293A1 Staphylococcus 3-dehydroquinate synthase |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968285A1 Morphogenic proteins |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968210A1 Method of making arylamino triazolopyridines |
| 01/05/2000 | EP0968209A1 THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968201A2 New aminopiperazine derivatives |
| 01/05/2000 | EP0968200A1 Calcitonin mimetics |
| 01/05/2000 | EP0968199A1 Antibacterial heterocyclic amino acid derivatives |
| 01/05/2000 | EP0968194A1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 01/05/2000 | EP0968186A1 Improved polyamides for binding in the minor groove of double stranded dna |